(Reuters) – The U.S. Food and Drug Administration on Thursday recommended the inclusion of Omicron BA.4 and BA.5 subvariants as a part of COVID-19 booster doses. The regulators move comes after advisers to the health regulator on Tuesday recommended a change in the design of COVID-19 booster shots …

Source link

By admin

Leave a Reply

Your email address will not be published. Required fields are marked *